Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadeh, Elaheh Kordzadeh-Kermani, Benjamin W. Van Tassell, Azin Gheymati, Hamid Ariannejad, Seyed Hossein Hosseini, Sepehr Jamalkhani, Michelle Sholzberg, Manuel Monreal, David Jimenez, Gregory Piazza, Sahil A. Parikh, Ajay Kirtane, John W. Eikelboom, Jean M. Connors, Beverley J. Hunt, Stavros V. Konstantinides, Mary Cushman, Jeffrey I. Weitz, Gregg W. Stone, View ORCID ProfileHarlan M. Krumholz, Gregory Y.H. Lip, Samuel Z. Goldhaber, Behnood Bikdeli
doi: https://doi.org/10.1101/2021.01.04.21249227
Azita H. Talasaz
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
2Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Parham Sadeghipour
3Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hessam Kakavand
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
2Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryam Aghakouchakzadeh
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaheh Kordzadeh-Kermani
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin W. Van Tassell
4Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.
5Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azin Gheymati
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamid Ariannejad
2Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seyed Hossein Hosseini
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sepehr Jamalkhani
20McMaster University, Hamilton, Ontario, Canada.
21Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.
3Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Sholzberg
6Departments of Medicine and Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Canada.
7Department of Medicine, St. Michael’s Hospital, Toronto, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Monreal
8Department of Internal Medicine, Hospital Universitari Germans Trials i Pujol, Universidad Católica San Antonio de Murcia, Barcelona, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Jimenez
9Respiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad de Alcalá (Instituto de Ramón y Cajal de Investigación Sanitaria), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Piazza
10Cardiovascular Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sahil A. Parikh
11Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
12New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajay Kirtane
11Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
12New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John W. Eikelboom
13Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean M. Connors
14Hematology Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beverley J. Hunt
15Haemostasis and Thrombosis Centre, St Thomas’ Hospital, Westminster Bridge Road, London, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stavros V. Konstantinides
16Center for Thrombosis and Hemostasis, Johannes Gutenberg University of Mainz, Mainz, Germany.
17Department of Cardiology, Democritus University of Thrace, Greece.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Cushman
18Department of Medicine, University of Vermont Larner College of Medicine and University of Vermont Medical Center, Burlington, VT, USA.
19Department of Pathology and Laboratory Medicine, University of Vermont Larner College of Medicine and University of Vermont Medical Center, Burlington, VT, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey I. Weitz
20McMaster University, Hamilton, Ontario, Canada.
21Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregg W. Stone
11Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
22Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harlan M. Krumholz
23Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, CT, USA.
24Department of Health Policy and Administration, Yale School of Public Health, New Haven, CT, USA.
25Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Harlan M. Krumholz
Gregory Y.H. Lip
26Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University of Liverpool, Liverpool, United Kingdom.
27Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel Z. Goldhaber
10Cardiovascular Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Behnood Bikdeli
10Cardiovascular Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
11Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
23Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, CT, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bbikdeli@bwh.harvard.edu Behnood.bikdeli@yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiologic features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of COVID-19. A variety of antithrombotic agents, doses and durations of therapy are being assessed in ongoing randomized controlled trials (RCTs) that focus on outpatients, hospitalized patients in medical wards, and critically-ill patients with COVID-19. This manuscript provides a perspective of the ongoing or completed RCTs related to antithrombotic strategies used in COVID-19, the opportunities and challenges for the clinical trial enterprise, and areas of existing knowledge, as well as data gaps that may motivate the design of future RCTs.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • FUNDING: None

  • TWEET: Several #RCTs are underway to understand the optimal prophylactic #antithrombotic regimen across the spectrum of disease severity in patients with #COVID19.

Data Availability

N/A

  • ABBREVIATIONS AND ACRONYMS

    COVID-19
    coronavirus disease 2019
    DOAC
    direct oral anticoagulant
    DTI
    direct thrombin inhibitor
    ICU
    intensive care unit
    LMWH
    low molecular weight heparin
    RCT
    randomized controlled trial
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus 2
    UFH
    unfractionated heparin
    VTE
    venous thromboembolism
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted January 06, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials
    Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadeh, Elaheh Kordzadeh-Kermani, Benjamin W. Van Tassell, Azin Gheymati, Hamid Ariannejad, Seyed Hossein Hosseini, Sepehr Jamalkhani, Michelle Sholzberg, Manuel Monreal, David Jimenez, Gregory Piazza, Sahil A. Parikh, Ajay Kirtane, John W. Eikelboom, Jean M. Connors, Beverley J. Hunt, Stavros V. Konstantinides, Mary Cushman, Jeffrey I. Weitz, Gregg W. Stone, Harlan M. Krumholz, Gregory Y.H. Lip, Samuel Z. Goldhaber, Behnood Bikdeli
    medRxiv 2021.01.04.21249227; doi: https://doi.org/10.1101/2021.01.04.21249227
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials
    Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadeh, Elaheh Kordzadeh-Kermani, Benjamin W. Van Tassell, Azin Gheymati, Hamid Ariannejad, Seyed Hossein Hosseini, Sepehr Jamalkhani, Michelle Sholzberg, Manuel Monreal, David Jimenez, Gregory Piazza, Sahil A. Parikh, Ajay Kirtane, John W. Eikelboom, Jean M. Connors, Beverley J. Hunt, Stavros V. Konstantinides, Mary Cushman, Jeffrey I. Weitz, Gregg W. Stone, Harlan M. Krumholz, Gregory Y.H. Lip, Samuel Z. Goldhaber, Behnood Bikdeli
    medRxiv 2021.01.04.21249227; doi: https://doi.org/10.1101/2021.01.04.21249227

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (63)
    • Allergy and Immunology (145)
    • Anesthesia (47)
    • Cardiovascular Medicine (420)
    • Dentistry and Oral Medicine (74)
    • Dermatology (49)
    • Emergency Medicine (148)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (176)
    • Epidemiology (4910)
    • Forensic Medicine (3)
    • Gastroenterology (185)
    • Genetic and Genomic Medicine (691)
    • Geriatric Medicine (73)
    • Health Economics (193)
    • Health Informatics (637)
    • Health Policy (325)
    • Health Systems and Quality Improvement (209)
    • Hematology (87)
    • HIV/AIDS (157)
    • Infectious Diseases (except HIV/AIDS) (5416)
    • Intensive Care and Critical Care Medicine (335)
    • Medical Education (96)
    • Medical Ethics (24)
    • Nephrology (77)
    • Neurology (692)
    • Nursing (42)
    • Nutrition (115)
    • Obstetrics and Gynecology (130)
    • Occupational and Environmental Health (211)
    • Oncology (448)
    • Ophthalmology (140)
    • Orthopedics (36)
    • Otolaryngology (91)
    • Pain Medicine (37)
    • Palliative Medicine (18)
    • Pathology (132)
    • Pediatrics (203)
    • Pharmacology and Therapeutics (131)
    • Primary Care Research (88)
    • Psychiatry and Clinical Psychology (789)
    • Public and Global Health (1833)
    • Radiology and Imaging (328)
    • Rehabilitation Medicine and Physical Therapy (142)
    • Respiratory Medicine (260)
    • Rheumatology (88)
    • Sexual and Reproductive Health (69)
    • Sports Medicine (63)
    • Surgery (102)
    • Toxicology (23)
    • Transplantation (29)
    • Urology (39)